Journal of Oncology Practice 2014-12-01

Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.

Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov, Hairong Xu, GaryH Lyman

文献索引：J. Oncol. Pract. , (2014)

全文：HTML全文

摘要

Although studies have evaluated the risk and consequences of febrile neutropenia (FN) among patients receiving cancer chemotherapy in US clinical practice, none have focused on a broad group of patients with metastatic disease.